1 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Rewind Therapeutics Funding History

Since Rewind Therapeutics was founded in 2017, it has participated in 3 rounds of funding. In total Rewind Therapeutics has raised $21.5M. Rewind Therapeutics' last funding round was on Jan 2023 for a total of $0.

Rewind Therapeutics Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Series A
Jan 2023
--
5
Boehringer Ingelheim Venture Fund,  M. Ventures,  PMV,  CD3/ KU,  Sunstone Life Science Ventures
Grant
Jul 2019
$3.2M
__
Series A
Jan 2018
$18.3M
4
Boehringer Ingelheim Venture Fund,  Merck Ventures BV,  Participatiemaatschappij Vlaanderen,  KU Leuven's Centre for Drug Design and Discovery (CD3)

Total Funding: $21.5M

Rewind Therapeutics Investors

Unlock 5 more investors →

INVESTOR

ROUND

FUNDING DATE

Boehringer Ingelheim Venture Fund
Series A
Jan 2023, Jan 2018
M. Ventures
Series A
Jan 2023
PMV
Series A
Jan 2023
CD3/ KU
Series A
Jan 2023
Sunstone Life Science Ventures
Series A
Jan 2023

Total Investors: 8

Rewind Therapeutics has 8 investors, including Boehringer Ingelheim Venture Fund, M. Ventures and PMV. The latest investment occurred in Jan 2023.